Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Project Overview:

The aim of our group is to understand pathogenic epigenetic mechanisms in a variety of musculoskeletal diseases, comprising inflammatory (eg autoimmune diseases) and malignant processes (eg bone cancer) and stem cells (eg mesenchymal and haematopoietic). We are positioned to investigate this effectively via

(1) excellent interactions with clinical colleagues, and

(2) through collaboration with the Structural Genomics Consortium (SGC), an international public-private partnership, to develop and evaluate unique small molecule inhibitors to probe biological functions of epigenetic targets in a disease context.

Training:

Several aspects of molecular biology techniques are established in the group, and comprise cell culture (primary, continuous cell lines), protein purification and characterisation, various types of assays (including enzyme, apoptosis, proliferation), flow and mass cytometry, next generation sequencing and data analysis. Other skill sets such as presentation and communication abilities, team working and multi-tasking are important parameters for success. It is expected that any candidate will be successfully acquiring any of these skill sets, depending on their training needs.

RELEVANT PUBLICATIONS